𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Levodopa and the progression of Parkinson’s disease

✍ Scribed by John Morgan; Kapil D. Sethi

Publisher
Springer
Year
2005
Tongue
English
Weight
194 KB
Volume
5
Category
Article
ISSN
1528-4042

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The need for levodopa as an end point of
The need for levodopa as an end point of Parkinson's disease progression in a clinical trial of selegiline and α-tocopherol
✍ Dr. Peter LeWitt; David Oakes; Lu Cui 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 693 KB

## Abstract Progression of Parkinson's disease (PD) can be detected through changes in clinical ratings or disability assessments. A clinical trial, Deprenyl and Alpha‐Tocopherol Antioxidative Therapy of Parkinsonism (DATATOP), used a novel study end point: increase in parkinsonian disability to th

Differential progression of motor impair
Differential progression of motor impairment in levodopa-treated Parkinson's disease
✍ Christopher G. Goetz; Glenn T. Stebbins; Lucy M. Blasucci 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB 👁 2 views

OBJECTIVE: To monitor comparative progression of clinical impairment over 4 years in patients with Parkinson's disease (PD) who present on levodopa at two different levels of Hoehn and Yahr (HY) stages, II and III. BACKGROUND: The rate of clinical impairment progression in patients with PD being tr